Phase1 trial of Cetuximab/S-1 combination therapy for Advanced/Recurrent Colorectal Cancer - Phase1 trial of Cetuximab/S-1 combination therapy for Advanced/Recurrent Colorectal Cancer

Kinki university school of medicine Department of clinical oncology0 个研究点目标入组 21 人开始时间: 2010年8月30日最近更新: 2023年10月17日

试验速览

暂无简介。

•(1)A case with the interstitial pneumonia that is clear by chest CT or pulmonary fibrosis. (2)A case receiving flucytosine (a pyrimidine system antifungal agent fluoride). (3)A case with a history of serious drug allergy. (4)The case with pleural effusion, ascitic fluid needing treatment such as the drainage and the pericardial fluid. (5) The case with serious heart disorder, myocardial infarction within six months, hypertension having poor control, bacterial infection and fungal infection of the activity and other serious complications (haemorrhage of digestive tract). (6)A case to have a short bowel syndrome merger or diarrhea (watery feces) continuously. (7) Intestinal paralysis, a case with bowel obstruction. (8) Metastases to brain case with the symptom.A case (as for the metastases to brain case that a symptom was stable by metastases to brain case and radiotherapy and medical treatment without the symptom, possible registration) to need the antihydropic including the steroid of the symptom control purpose. (9)A case with the diabetes mellitus inadequate control. (10)The case that it was judged mental disorder to become the clinical problem to have difficulty in registration to this study. (11)A case to have pregnant or pregnant possibilities, the case that there is not of the intention to prevent conception and the case that we are nursing. (12)In addition, the case that we judged to be inadequate though the medical attendants conducted this study

发起方

Kinki university school of medicine Department of clinical oncology